• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

ECTRIMS 2024 HIGHLIGHTS – FRIDAY, SEPTEMBER 20, 2024

September 20, 2024  

ECTRIMS 2024 HIGHLIGHTS – THURSDAY, SEPTEMBER 19, 2024

September 19, 2024  

ECTRIMS 2024 HIGHLIGHTS – WEDNESDAY, SEPTEMBER 18, 2024

September 18, 2024  

Does MS burn out?

August 20, 2024  

Utility of biomarkers in progressive MS

August 1, 2024  

Protein biomarker panel useful for MS diagnosis, prognosis

July 23, 2024  

REPORT FROM EAN 2024 – THURSDAY, JULY 4, 2024

July 4, 2024  

REPORT FROM EAN 2024 – WEDNESDAY, JULY 3, 2024

July 3, 2024  

REPORT FROM EAN 2024 – TUESDAY, JULY 2, 2024

July 2, 2024  

Inertia and uncertainty: is MS treatment truly optimized?

June 25, 2024  
Previous
1
2
3
4
5
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions